about
Multiple asparagine deamidation of Bacillus anthracis protective antigen causes charge isoforms whose complexity correlates with reduced biological activity.Identification of in vivo-induced conserved sequences from Yersinia pestis during experimental plague infection in the rabbit.Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plagueProtection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.Development of in vitro correlate assays of immunity to infection with Yersinia pestis.Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague.Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection.Prevalence of and risk factors associated with ovine progressive pneumonia in Wyoming sheep flocks.CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.Antibodies and cytokines independently protect against pneumonic plague.Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice.Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies.
P50
Q33283213-9F86416A-ACEF-4427-8C25-572C3E3C0E80Q33522435-7B31B769-48C8-43E3-8DB7-90A015564EEFQ33612949-25E6978A-03FB-4368-98B0-450DBA6A4300Q33798021-30BE39A6-4204-492C-A69C-16932D8DF6E9Q33946563-95914370-4690-48A0-A32A-E72336C8F354Q34380204-12EAE3EF-E878-4AEA-9059-C23861170005Q35783560-DE8179B3-4CCD-4060-A79B-00D55040F2C6Q36804213-14FE58D0-0075-4E3E-96E6-9C7699065A72Q37117600-54304F65-58BD-4FEA-9204-0B628064DACEQ39755573-444926DC-7BD8-4BE4-BE84-3945E4102217Q40974080-ED4DF0E7-0F82-4A95-9A69-87A2C1EE47ACQ41438984-9102A0AD-AA4F-426E-8DEF-A813DC9CC971Q41441607-01B59477-D968-488B-93E4-11B214F61D0DQ41443662-ACB96B1E-6FCD-4F1E-90EF-FC5EA380C283Q41456630-1F0DF0FA-DA89-402E-9A09-5D56E0314B80Q46536685-C8490BC3-6708-4A2B-AEB5-84D8132F0F50
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jeffrey J Adamovicz
@ast
Jeffrey J Adamovicz
@en
Jeffrey J Adamovicz
@es
Jeffrey J Adamovicz
@nl
Jeffrey J Adamovicz
@sl
type
label
Jeffrey J Adamovicz
@ast
Jeffrey J Adamovicz
@en
Jeffrey J Adamovicz
@es
Jeffrey J Adamovicz
@nl
Jeffrey J Adamovicz
@sl
prefLabel
Jeffrey J Adamovicz
@ast
Jeffrey J Adamovicz
@en
Jeffrey J Adamovicz
@es
Jeffrey J Adamovicz
@nl
Jeffrey J Adamovicz
@sl
P106
P31
P496
0000-0002-1824-3268